BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2545335)

  • 1. Dipyridamole enhancement of etoposide sensitivity.
    Howell SB; Hom DK; Sanga R; Vick JS; Chan TC
    Cancer Res; 1989 Aug; 49(15):4147-53. PubMed ID: 2545335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole.
    Howell SB; Hom D; Sanga R; Vick JS; Abramson IS
    Cancer Res; 1989 Jun; 49(12):3178-83. PubMed ID: 2720673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro.
    Shalinsky DR; Andreeff M; Howell SB
    Cancer Res; 1990 Dec; 50(23):7537-43. PubMed ID: 1979245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro.
    Jekunen A; Vick J; Sanga R; Chan TC; Howell SB
    Cancer Res; 1992 Jul; 52(13):3566-71. PubMed ID: 1617625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
    Maca RD
    Anticancer Drug Des; 1991 Nov; 6(5):453-66. PubMed ID: 1722410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of activities of anti-tumor drugs by dipyridamole against multidrug-resistant human hepatoma PLC/PRF/5 cells.
    Tatsuta T; Shimizu K; Nishimura T; Suzuki H
    Anticancer Drug Des; 1991 Jul; 6(3):179-88. PubMed ID: 1678605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
    Politi PM; Sinha BK
    Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts.
    White JC; Hines LH; Rathmell JP
    Cancer Res; 1985 Jul; 45(7):3070-5. PubMed ID: 4005845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of microtubule inhibitors on etoposide accumulation and DNA damage in human K562 cells in vitro.
    Yalowich JC
    Cancer Res; 1987 Feb; 47(4):1010-5. PubMed ID: 2879622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor.
    Sato S; Kohno K; Hidaka K; Hisatsugu T; Kuwano M; Komiyama S
    Anticancer Drug Des; 1993 Aug; 8(4):289-97. PubMed ID: 8240657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene.
    Lorico A; Rappa G; Srimatkandada S; Catapano CV; Fernandes DJ; Germino JF; Sartorelli AC
    Cancer Res; 1995 Oct; 55(19):4352-60. PubMed ID: 7671247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
    Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.
    Jarvis SM
    Mol Pharmacol; 1986 Dec; 30(6):659-65. PubMed ID: 3785142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis.
    Chiu CC; Lin CH; Fang K
    Apoptosis; 2005 May; 10(3):643-50. PubMed ID: 15909125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin.
    Rappa G; Lorico A; Sartorelli AC
    Cancer Res; 1993 Nov; 53(22):5487-93. PubMed ID: 8106148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of 1-beta-D-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibiting drug efflux.
    Chan TC
    Cancer Res; 1989 May; 49(10):2656-60. PubMed ID: 2713849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate.
    Plagemann PG
    J Cell Physiol; 1986 Sep; 128(3):491-500. PubMed ID: 3488996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport.
    Chen HX; Bamberger U; Heckel A; Guo X; Cheng YC
    Cancer Res; 1993 May; 53(9):1974-7. PubMed ID: 8097671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide, cGMP and cAMP modulate nitrobenzylthioinosine-sensitive adenosine transport in human umbilical artery smooth muscle cells from subjects with gestational diabetes.
    Aguayo C; Sobrevia L
    Exp Physiol; 2000 Jul; 85(4):399-409. PubMed ID: 10918079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.